Background
To investigate the effects of hypoxia-inducible factor-1α (HIF-1α) on the viability and migration of diffuse large B cell lymphoma (DLBCL) cells and the underlying mechanisms.
Methods
HIF-1α overexpression and knockdown plasmids were constructed and transfected into DLBCL cells. The efficacy of HIF-1α expression was detected via real time quantitative polymerase chain reaction (RT-qPCR). Whether overexpression and knockdown HIF-1α affect the expression of chemokine receptor type 4 (CXCR4) and promote cells proliferation and migration were detected via CCK8 assay and Transwell assay. How HIF-1α works on CXCR4 was measured by double fluorescent reporter assay and chromatin immunoprecipitation (ChIP) assay. The expression level of CXCR4 and AKT/mTOR pathway-related proteins were detected via Western blot assay.
Results
CCK8 assay and Transwell assay showed that both hypoxic conditions and HIF-1α overexpression under normoxia promoted the viability and migration of DLBCL cells while HIF-1α knockdown showed inhibitory effects. The effects of HIF-1α on DLBCL cells were suppressed when the expression of CXCR4 was inhibited. Double fluorescent reporter enzyme assay and ChIP assay showed that HIF-1α combined with the functional site HRE1 of CXCR4 promoter to promote the transcription of CXCR4. Western blot assay demonstrated that HIF-1α promoted the expression of CXCR4 to activate the phosphorylation of AKT/mTOR pathway under hypoxia.
Conclusion
HIF-1α regulated CXCR4 by binding to the functional site HRE1 of CXCR4 promoter and further activate AKT / mTOR signaling pathway, thereby promoting the viability and migration of DLBCL cells under hypoxia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.